Publication:
Intratympanic steroid for residual dizziness after benign paroxysmal positional vertigo: a randomized controlled study.

dc.contributor.authorDogan R.
dc.contributor.authorPolat E.
dc.contributor.authorSenturk E.
dc.contributor.authorYenigun A.
dc.contributor.authorEren S. B.
dc.contributor.authorAksoy F.
dc.contributor.authorKucuk R. B.
dc.contributor.authorOzturan O.
dc.date.accessioned2026-04-08T21:37:54Z
dc.date.issued2026-02-26
dc.identifier.citationDogan R., Polat E., Senturk E., Yenigun A., Eren S. B., Aksoy F., Kucuk R. B., Ozturan O., "Intratympanic steroid for residual dizziness after benign paroxysmal positional vertigo: a randomized controlled study.", Acta otorrinolaringologica espanola, ss.512330, 2026
dc.identifier.doi10.1016/j.otoeng.2026.512330
dc.identifier.pubmed41763397
dc.identifier.urihttps://hdl.handle.net/20.500.12645/41878
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleIntratympanic steroid for residual dizziness after benign paroxysmal positional vertigo: a randomized controlled study.
dc.typearticle
dspace.entity.typePublication
local.avesis.idd369d9da-baed-4275-98c9-9c6f3e6d7064

Files